Albuminuria is independently associated with cardiac remodeling, abnormal right and left ventricular function, and worse outcomes in heart failure with preserved ejection fraction

JACC: Heart Failure

Volumn 2, Issue 6, 2014, Pages 586-596

  Katz, Daniel H ^a   Burns, Jacob A ^a   Aguilar, Frank G ^a   Beussink, Lauren ^a   Shah, Sanjiv J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Albuminuria; Diastolic heart failure; Endothelial dysfunction; Ventricular function; Ventricular remodeling

Indexed keywords

ALBUMIN; CREATININE;

AGED; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE MASS; HEART PRELOAD; HEART RIGHT VENTRICLE FAILURE; HEART STROKE VOLUME; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SYSTOLIC DYSFUNCTION; TISSUE DOPPLER IMAGING; COMPLICATION; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE FUNCTION; KAPLAN MEIER METHOD; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; URINE;

AGED; ALBUMINURIA; CREATININE; FEMALE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; PROGNOSIS; PROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR REMODELING;

EID: 84959935666     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2014.05.016     Document Type: Article

References (39)

1. Hillege H.L., Fidler V., Diercks G.F., et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002, 106:1777-1782. for the Prevention of Renal and Vascular End State Disease (PREVEND) Study Group.
2. Arnlov J., Evans J.C., Meigs J.B., et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005, 112:969-975.
3. Deckert T., Yokoyama H., Mathiesen E., et al. Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes. BMJ 1996, 312:871-874.
4. Miettinen H., Haffner S.M., Lehto S., Rönnemaa T., Pyorälä K., Laakso M. Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke 1996, 27:2033-2039.
5. Solomon S.D., Lin J., Solomon C.G., et al. Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease. Circulation 2007, 116:2687-2693. for the Prevention of Events With ACE Inhibition (PEACE) Investigators.
6. Jackson C.E., Solomon S.D., Gerstein H.C., et al. Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet 2009, 374:543-550. for the CHARM Investigators and Committees.
7. Jackson C.E., MacDonald M.R., Petrie M.C., et al. Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study. Eur J Heart Fail 2011, 13:746-754. for the ALiskiren Observation of heart Failure Treatment study (ALOFT) Investigators.
8. Masson S., Latini R., Milani V., et al. Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure: data from the GISSI-Heart Failure trial. Circ Heart Fail 2010, 3:65-72. on behalf of the GISSI-HF Investigators.
9. Miura M., Shiba N., Nochioka K., et al. Urinary albumin excretion in heart failure with preserved ejection fraction: an interim analysis of the CHART 2 study. Eur J Heart Fail 2012, 14:367-376. on behalf of the CHART-2 Investigators.
10. Brouwers F.P., de Boer R.A., van der Harst P., et al. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J 2013, 34:1424-1431.
11. Djousse L., Kochar J., Hunt S.C., et al. Relation of albuminuria to left ventricular mass (from the HyperGEN Study). Am J Cardiol 2008, 101:212-216.
12. Weir M.R. Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol 2007, 2:581-590.
13. Akiyama E., Sugiyama S., Matsuzawa Y., et al. Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction. JAm Coll Cardiol 2012, 60:1778-1786.
14. Matsubara J., Sugiyama S., Nozaki T., et al. Pentraxin 3 is a new inflammatory marker correlated with left ventricular diastolic dysfunction and heart failure with normal ejection fraction. JAm Coll Cardiol 2011, 57:861-869.
15. Puwanant S., Priester T.C., Mookadam F., Bruce C.J., Redfield M.M., Chandrasekaran K. Right ventricular function in patients with preserved and reduced ejection fraction heart failure. Eur J Echocardiogr 2009, 10:733-737.
16. Morris D.A., Gailani M., Vaz Pérez A., et al. Right ventricular myocardial systolic and diastolic dysfunction in heart failure with normal left ventricular ejection fraction. JAm Soc Echocardiogr 2011, 24:886-897.
17. McKee P.A., Castelli W.P., McNamara P.M., Kannel W.B. The natural history of congestive heart failure: the Framingham study. NEngl J Med 1971, 285:1441-1446.
18. Paulus W.J., Tschöpe C., Sanderson J.E., et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007, 28:2539-2550.
19. Paulus W.J., van Ballegoij J.J. Treatment of heart failure with normal ejection fraction: an inconvenient truth!. JAm Coll Cardiol 2010, 55:526-537.
20. Lang R.M., Bierig M., Devereux R.B., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. JAm Soc Echocardiogr 2005, 18:1440-1463.
21. Nagueh S.F., Appleton C.P., Gillebert T.C., et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. JAm Soc Echocardiogr 2009, 22:107-133.
22. Rudski L.G., Lai W.W., Afilalo J., et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. JAm Soc Echocardiogr 2010, 23:685-713. quiz 786-8.
23. Redfield M.M., Jacobsen S.J., Burnett J.C., Mahoney D.W., Bailey K.R., Rodeheffer R.J. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003, 289:194-202.
24. Lee W.S., Huang W.P., Yu W.C., Chiou K.R., Ding P.Y., Chen C.H. Estimation of preload recruitable stroke work relationship by a single-beat technique in humans. Am J Physiol Heart Circ Physiol 2003, 284:H744-H750.
25. Feneley M.P., Skelton T.N., Kisslo K.B., Davis J.W., Bashore T.M., Rankin J.S. Comparison of preload recruitable stroke work, end-systolic pressure-volume and dP/dtmax-end-diastolic volume relations as indexes of left-ventricular contractile performance in patients undergoing routine cardiac-catheterization. JAm Coll Cardiol 1992, 19:1522-1530.
26. Takeuchi M., Odake M., Takaoka H., Hayashi Y., Yokoyama M. Comparison between preload recruitable stroke work and the end-systolic pressure-volume relationship in man. Eur Heart J 1992, 13:80-84.
27. Willis J., Augustine D., Shah R., Stevens C., Easaw J. Right ventricular normal measurements: time to index?. JAm Soc Echocardiogr 2012, 25:1259-1267.
28. Lam C.S., Roger V.L., Rodeheffer R.J., Borlaug B.A., Enders F.T., Redfield M.M. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. JAm Coll Cardiol 2009, 53:1119-1126.
29. Ommen S.R., Nishimura R.A., Hurrell D.G., Klarich K.W. Assessment of right atrial pressure with 2-dimensional and Doppler echocardiography: a simultaneous catheterization and echocardiographic study. Mayo Clin Proc 2000, 75:24-29.
30. Storey J.D. Adirect approach to false discovery rates. JR Stat Soc Series B Stat Methodol 2002, 64:479-498.
31. Liu J.E., Robbins D.C., Palmieri V., et al. Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study. JAm Coll Cardiol 2003, 41:2022-2028.
32. Wegria R., Capeci N.E., Blumenthal M.R., et al. The pathogenesis of proteinuria in the acutely congested kidney. JClin Invest 1955, 34:737-743.
33. Shah A.M., Lam C.S., Cheng S., et al. The relationship between renal impairment and left ventricular structure, function, and ventricular-arterial interaction in hypertension. JHypertens 2011, 29:1829-1836.
34. Katz D.H., Selvaraj S., Aguilar F.G., et al. Association of low-grade albuminuria with adverse cardiac mechanics: findings from the Hypertension Genetic Epidemiology Network (HyperGEN) Study. Circulation 2014, 129:42-50.
35. Paulus W.J., Tschöpe C. Anovel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. JAm Coll Cardiol 2013, 62:263-271.
36. Thenappan T., Shah S.J., Gomberg-Maitland M., et al. Clinical characteristics of pulmonary hypertension in patients with heart failure and preserved ejection fraction. Circ Heart Fail 2011, 4:257-265.
37. Liu Y.W., Tsai W.C., Su C.T., Lin C.C., Chen J.H. Evidence of left ventricular systolic dysfunction detected by automated function imaging in patients with heart failure and preserved left ventricular ejection fraction. JCard Fail 2009, 15:782-789.
38. Borlaug B.A., Lam C.S., Roger V.L., Rodeheffer R.J., Redfield M.M. Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. JAm Coll Cardiol 2009, 54:410-418.
39. Nathan D.M., Rosenbaum C., Protasowicki V.D. Single-void urine samples can be used to estimate quantitative microalbuminuria. Diabetes Care 1987, 10:414-418.